Dr. Sahni joined the BUSM faculty as an instructor of Dermatology and staff dermatologist at Boston Medical Center in 2011. She was promoted to assistant professor in 2012 and serves as director of the multi-disciplinary Cutaneous Oncology Program. She specializes in the care of cutaneous oncology patients, including cutaneous lymphomas and the medical management of melanoma and high-risk non-melanoma skin cancers. Dr. Sahni also directs the Cutaneous Oncology Fellowship and the International Program in Dermatology (IGPD). First established in 1988, the IGPD offers international postgraduate doctors the opportunity to train in dermatology, utilizing state-of-the-art facilities and therapies available in the US. Dr. Sahni’s clinical research interests focus on the epidemiology and treatment of skin cancers. She is a member of the Medical Advisory Council for the Cutaneous Lymphoma Foundation. Her academic interests include teaching and mentoring. She has lectured both in Europe and the US, and is the author of a number of scientific papers. Since her arrival seven years ago, she has received four Department of Dermatology Teacher of the Year awards. Dr. Sahni received her MBBS from the United Medical and Dental Schools of Guy’s and St Thomas’ Hospitals in London. After finishing her internal medicine residency she acquired her MRCP (Membership of the Royal College of Physicians) and completed a dermatology residency at the St John’s Institute of Dermatology in London followed by a cutaneous oncology fellowship at Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Boston.
- Director, Cutaneous Oncology, Dermatology, Boston University School of Medicine
- King's College London, MBBS
- King's College London, BSc
- Published on 10/3/2018
Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB. Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials. Cancer. 2018 Oct 03. PMID: 30281145.
- Published on 5/29/2018
Ho JD, Al-Haseni A, Smith S, Bhawan J, Sahni D. Bullous complex regional pain syndrome: A description of the clinical and histopathologic features. J Cutan Pathol. 2018 Aug; 45(8):633-635. PMID: 29704267.
- Published on 5/19/2018
Singh B, Qureshi MM, Truong MT, Sahni D. Optimal Surgical Modality for Early Merkel Cell Carcinoma-Results from the National Cancer Data Base. J Am Acad Dermatol. 2018 May 19. PMID: 29787838.
- Published on 3/15/2018
Gionfriddo MR, Pulk RA, Sahni DR, Vijayanagar SG, Chronowski JJ, Jones LK, Evans MA, Feldman SR, Pride H. ProvenCare-Psoriasis: A disease management model to optimize care. Dermatol Online J. 2018 Mar 15; 24(3). PMID: 29634876.
- Published on 2/3/2018
Singh B, Qureshi MM, Truong MT, Sahni D. Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database. J Am Acad Dermatol. 2018 Jul; 79(1):126-134.e3. PMID: 29408552.
- Published on 1/15/2018
Min MS, Al-Haseni A, Succaria F, Goldberg L, Lerner A, Sahni D. Anaplastic large cell lymphoma localized to the left breast years after radiotherapy for breast cancer. Dermatol Online J. 2018 Jan 15; 24(1). PMID: 29469762.
- Published on 10/4/2017
Al-Haseni A, Chitgopeker P, Ho JD, Goldberg LJ, Sahni D. Amelanotic melanoma arising within a lesion of disseminated superficial actinic porokeratosis: An unusual presentation leading to a novel therapeutic approach. Dermatol Ther. 2018 Jan; 31(1). PMID: 28976625.
- Published on 10/1/2017
Patel SA, Qureshi MM, Sahni D, Truong MT. Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection: An Analysis of the National Cancer Database. JAMA Dermatol. 2017 Oct 01; 153(10):1007-1014. PMID: 28746702.
- Published on 9/4/2017
Ho JD, Kam SA, Al-Haseni A, Markova A, Sahni D, Lam C, Goldberg LJ, Bhawan J. Benign and malignant hybrid adnexal tumors in a patient with epidermodysplasia verruciformis. J Cutan Pathol. 2017 Nov; 44(11):969-973. PMID: 28796338.
- Published on 3/29/2017
Patel SA, Qureshi MM, Mak KS, Sahni D, Giacalone NJ, Ezzat W, Jalisi S, Truong MT. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection. Head Neck. 2017 Jul; 39(7):1371-1377. PMID: 28370725.
View 10 more publications: View full profile at BUMC